|
|
 Previous Article | Table of Contents | Next Article 
The PML gene encodes a phosphoprotein associated with the nuclear matrix
KS Chang, YH Fan, M Andreeff, J Liu and ZM Mu
Department of Hematology, University of Texas M.D. Anderson Cancer Center,
Houston 77030, USA.
The t(15;17)(q22;q12) translocation is the cytogenetic hallmark of acute
promyelocytic leukemia (APL). The PML and retinoic acid receptor- alpha
(RAR alpha) transcription factor genes are involved at translocation
breakpoint. To elucidate the biologic function of PML, antipeptide antibody
against PML protein was raised in rabbits. This antibody was able to detect
a 90-kD PML protein and a 110-kD PML-RAR alpha fusion protein by Western
blotting and a nuclear speckled pattern in all cell lines by
immunofluorescent staining. In K562 and NIH/3T3 cells transfected with a
PML expression plasmid, we found PML to be associated with the nuclear
matrix. Our results also showed that PML is a phosphorprotein. A weak
signal was detected in a Western blot containing the immunoprecipitated PML
protein using the phosphotyrosine- specific monoclonal antibody. Therefore,
at least one of the sites was phosphorylated by a tyrosine kinase. From our
analysis of the phosphoamino acids of the PML protein by complete
hydrolysis and thin- layer chromatography, we concluded that both tyrosine
and serine residues of PML are phosphorylated. To investigate whether
expression of the PML protein is cell-cycle related, HeLa cells
synchronized at various phases of the cell cycle were analyzed by
immunofluorescence staining and confocal microscopy for PML expression. We
found that PML was expressed at a lower level in S, G2, and M phases and at
a significantly higher level in G1 phase. Our study showed that PML has
many similar properties compared with the tumor suppressor, eg, Rb. These
findings further support the important role of PML in APL pathogenesis.
Volume 85,
Issue 12,
pp. 3646-3653,
06/15/1995
Copyright © 1995 by The American Society of Hematology
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
G. Dellaire, R. W. Ching, H. Dehghani, Y. Ren, and D. P. Bazett-Jones
The number of PML nuclear bodies increases in early S phase by a fission mechanism
J. Cell Sci.,
March 15, 2006;
119(6):
1026 - 1033.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Dellaire, C. H. Eskiw, H. Dehghani, R. W. Ching, and D. P. Bazett-Jones
Mitotic accumulations of PML protein contribute to the re-establishment of PML nuclear bodies in G1
J. Cell Sci.,
March 15, 2006;
119(6):
1034 - 1042.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Shin, B. Park, S. Cho, S. Lee, Y. Kim, S.-O. Lee, K. Cho, S. Lee, B.-S. Jin, J.-H. Ahn, et al.
Promyelocytic Leukemia Is a Direct Inhibitor of SAPK2/p38 Mitogen-activated Protein Kinase
J. Biol. Chem.,
September 24, 2004;
279(39):
40994 - 41003.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Akiyoshi, S. Hatakeyama, J. Pitkanen, Y. Mouri, V. Doucas, J. Kudoh, K. Tsurugaya, D. Uchida, A. Matsushima, K. Oshikawa, et al.
Subcellular Expression of Autoimmune Regulator Is Organized in a Spatiotemporal Manner
J. Biol. Chem.,
August 6, 2004;
279(32):
33984 - 33991.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. H. Eskiw, G. Dellaire, and D. P. Bazett-Jones
Chromatin Contributes to Structural Integrity of Promyelocytic Leukemia Bodies through a SUMO-1-independent Mechanism
J. Biol. Chem.,
March 5, 2004;
279(10):
9577 - 9585.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Fuchsova, P. Novak, J. Kafkova, and P. Hozak
Nuclear DNA helicase II is recruited to IFN-{alpha}-activated transcription sites at PML nuclear bodies
J. Cell Biol.,
August 5, 2002;
158(3):
463 - 473.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. H. Miller Jr., H. M. Schipper, J. S. Lee, J. Singer, and S. Waxman
Mechanisms of Action of Arsenic Trioxide
Cancer Res.,
July 15, 2002;
62(14):
3893 - 3903.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Slack, S. Waxman, G. Tricot, M. S. Tallman, and C. D. Bloomfield
Advances in the Management of Acute Promyelocytic Leukemia and Other Hematologic Malignancies with Arsenic Trioxide
Oncologist,
April 1, 2002;
7(90001):
1 - 13.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Falini and D. Y. Mason
Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry
Blood,
January 15, 2002;
99(2):
409 - 426.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Sachdev, L. Bruhn, H. Sieber, A. Pichler, F. Melchior, and R. Grosschedl
PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies
Genes & Dev.,
December 1, 2001;
15(23):
3088 - 3103.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W.-S. Wu, S. Vallian, E. Seto, W.-M. Yang, D. Edmondson, S. Roth, and K.-S. Chang
The Growth Suppressor PML Represses Transcription by Functionally and Physically Interacting with Histone Deacetylases
Mol. Cell. Biol.,
April 1, 2001;
21(7):
2259 - 2268.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
S. K. Zaidi, A. Javed, J.-Y. Choi, A. J. van Wijnen, J. L. Stein, J. B. Lian, and G. S. Stein
A specific targeting signal directs Runx2/Cbfa1 to subnuclear domains and contributes to transactivation of the osteocalcin gene
J. Cell Sci.,
January 9, 2001;
114(17):
3093 - 3102.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. G. Berube, C. A. Smeenk, and D. J. Picketts
Cell cycle-dependent phosphorylation of the ATRX protein correlates with changes in nuclear matrix and chromatin association
Hum. Mol. Genet.,
March 1, 2000;
9(4):
539 - 547.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F.-M. Boisvert, M. J. Hendzel, and D. P. Bazett-Jones
Promyelocytic Leukemia (PML) Nuclear Bodies Are Protein Structures that Do Not Accumulate RNA
J. Cell Biol.,
January 24, 2000;
148(2):
283 - 292.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X.-F. Le, Y. Groner, S. M. Kornblau, Y. Gu, W. N. Hittelman, D. Levanon, K. Mehta, R. B. Arlinghaus, and K.-S. Chang
Regulation of AML2/CBFA3 in Hematopoietic Cells through the Retinoic Acid Receptor alpha -Dependent Signaling Pathway
J. Biol. Chem.,
July 30, 1999;
274(31):
21651 - 21658.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Melnick and J. D. Licht
Deconstructing a Disease: RAR{alpha}, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia
Blood,
May 15, 1999;
93(10):
3167 - 3215.
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Harada, Y. Harada, D. P. O'Brien, D. S. Rice, C. W. Naeve, and J. R. Downing
HERF1, a Novel Hematopoiesis-Specific RING Finger Protein, Is Required for Terminal Differentiation of Erythroid Cells
Mol. Cell. Biol.,
May 1, 1999;
19(5):
3808 - 3815.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D Pountney, G Trugnan, M Bourgeois, and C Beaumont
The identification of ferritin in the nucleus of K562 cells, and investigation of a possible role in the transcriptional regulation of adult beta-globin gene expression
J. Cell Sci.,
January 3, 1999;
112(6):
825 - 831.
[Abstract]
[PDF]
|
|
|
|
|
|
|
E Duprez, A. Saurin, J. Desterro, V Lallemand-Breitenbach, K Howe, M. Boddy, E Solomon, H de The, R. Hay, and P. Freemont
SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation
J. Cell Sci.,
January 2, 1999;
112(3):
381 - 393.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. Vallian, K.-V. Chin, and K.-S. Chang
The Promyelocytic Leukemia Protein Interacts with Sp1 and Inhibits Its Transactivation of the Epidermal Growth Factor Receptor Promoter
Mol. Cell. Biol.,
December 1, 1998;
18(12):
7147 - 7156.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
R. Shaknovich, P. L. Yeyati, S. Ivins, A. Melnick, C. Lempert, S. Waxman, A. Zelent, and J. D. Licht
The Promyelocytic Leukemia Zinc Finger Protein Affects Myeloid Cell Growth, Differentiation, and Apoptosis
Mol. Cell. Biol.,
September 1, 1998;
18(9):
5533 - 5545.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
D O'Rourke, G Elliott, M Papworth, R Everett, and P O'Hare
Examination of determinants for intranuclear localization and transactivation within the RING finger of herpes simplex virus type 1 IE110k protein
J. Gen. Virol.,
March 1, 1998;
79(3):
537 - 548.
[Abstract]
|
|
|
|
|
|
|
M. Alcalay, L. Tomassoni, E. Colombo, S. Stoldt, F. Grignani, M. Fagioli, L. Szekely, K. Helin, and P. G. Pelicci
The Promyelocytic Leukemia Gene Product (PML) Forms Stable Complexes with the Retinoblastoma Protein
Mol. Cell. Biol.,
February 1, 1998;
18(2):
1084 - 1093.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
P. M. Day, R. B. S. Roden, D. R. Lowy, and J. T. Schiller
The Papillomavirus Minor Capsid Protein, L2, Induces Localization of the Major Capsid Protein, L1, and the Viral Transcription/Replication Protein, E2, to PML Oncogenic Domains
J. Virol.,
January 1, 1998;
72(1):
142 - 150.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Grimwade, P. Gorman, E. Duprez, K. Howe, S. Langabeer, F. Oliver, H. Walker, D. Culligan, J. Waters, M. Pomfret, et al.
Characterization of Cryptic Rearrangements and Variant Translocations in Acute Promyelocytic Leukemia
Blood,
December 15, 1997;
90(12):
4876 - 4885.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. H. M. Koken, A. Reid, F. Quignon, M. K. Chelbi-Alix, J. M. Davies, J. H. S. Kabarowski, J. Zhu, S. Dong, S.-J. Chen, Z. Chen, et al.
Leukemia-associated retinoic acid receptor alpha fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies
PNAS,
September 16, 1997;
94(19):
10255 - 10260.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Brown, S. Kogan, E. Lagasse, I. Weissman, M. Alcalay, P. G. Pelicci, S. Atwater, and J. M. Bishop
A PMLRARalpha transgene initiates murine acute promyelocytic leukemia
PNAS,
March 18, 1997;
94(6):
2551 - 2556.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Muda, U. Boschert, A. Smith, B. Antonsson, C. Gillieron, C. Chabert, M. Camps, I. Martinou, A. Ashworth, and S. Arkinstall
Molecular Cloning and Functional Characterization of a Novel Mitogen-activated Protein Kinase Phosphatase, MKP-4
J. Biol. Chem.,
February 21, 1997;
272(8):
5141 - 5151.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Grisolano, R. L. Wesselschmidt, P. G. Pelicci, and T. J. Ley
Altered Myeloid Development and Acute Leukemia in Transgenic Mice Expressing PML-RARalpha Under Control of Cathepsin G Regulatory Sequences
Blood,
January 15, 1997;
89(2):
376 - 387.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Boddy, E Duprez, K. Borden, and P. Freemont
Surface residue mutations of the PML RING finger domain alter the formation of nuclear matrix-associated PML bodies
J. Cell Sci.,
January 9, 1997;
110(18):
2197 - 2205.
[Abstract]
[PDF]
|
|
|
|
|
|
|
B. Grondin, M. Bazinet, and M. Aubry
The KRAB Zinc Finger Gene ZNF74 Encodes an RNA-binding Protein Tightly Associated with the Nuclear Matrix
J. Biol. Chem.,
June 28, 1996;
271(26):
15458 - 15467.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X.-F. Le, P. Yang, and K.-S. Chang
Analysis of the Growth and Transformation Suppressor Domains of Promyelocytic Leukemia Gene, PML
J. Biol. Chem.,
January 5, 1996;
271(1):
130 - 135.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Shimono, H. Murakami, Y. Hasegawa, and M. Takahashi
RET Finger Protein Is a Transcriptional Repressor and Interacts with Enhancer of Polycomb That Has Dual Transcriptional Functions
J. Biol. Chem.,
December 8, 2000;
275(50):
39411 - 39419.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. T. Tse, J. Tang, O. Jin, C. Korsgren, K. M. John, A. L. Kung, B. Gwynn, L. L. Peters, and S. E. Lux
A New Spectrin, beta IV, Has a Major Truncated Isoform That Associates with Promyelocytic Leukemia Protein Nuclear Bodies and the Nuclear Matrix
J. Biol. Chem.,
June 22, 2001;
276(26):
23974 - 23985.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
